These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Elevated free tear lactoferrin levels in leprosy are associated with Type 2 reactions. Daniel E; Duriasamy M; Ebenezer GJ; Shobhana ; Job CK Indian J Ophthalmol; 2004 Mar; 52(1):51-6. PubMed ID: 15132380 [TBL] [Abstract][Full Text] [Related]
3. Serum samples from patients with mycobacterial infections cross-react with HIV structural proteins Gp41, p55 and p18. Hussain T; Sinha S; Katoch K; Yadav VS; Kulshreshtha KK; Singh I; Sengupta U; Katoch VM Lepr Rev; 2007 Jun; 78(2):137-47. PubMed ID: 17824484 [TBL] [Abstract][Full Text] [Related]
4. Cross-sectional assessment of ELISA reactivity in leprosy patients, contacts, and normal population using the semisynthetic antigen natural disaccharide octyl bovine serum albumin (ND-O-BSA) in Cebu, The Philippines. Cellona RV; Walsh GP; Fajardo TT; Abalos RM; dela Cruz EC; Guido-Villahermosa L; Felicio-Balagon MV; Steenbergen GJ; Douglas JT Int J Lepr Other Mycobact Dis; 1993 Jun; 61(2):192-8. PubMed ID: 8371027 [TBL] [Abstract][Full Text] [Related]
6. DDS-resistant infection among leprosy patients in the population of Gudiyatham Taluk, South India. Part 3. Prevalence, incidence, risk factors, and interpretation of mouse foot pad test results. Almeida JG; Chacko CJ; Christian M; Taylor PM; Fritschi EP Int J Lepr Other Mycobact Dis; 1983 Sep; 51(3):366-73. PubMed ID: 6685699 [TBL] [Abstract][Full Text] [Related]
7. An approach to understanding the transmission of Mycobacterium leprae using molecular and immunological methods: results from the MILEP2 study. Smith WC; Smith CM; Cree IA; Jadhav RS; Macdonald M; Edward VK; Oskam L; van Beers S; Klatser P Int J Lepr Other Mycobact Dis; 2004 Sep; 72(3):269-77. PubMed ID: 15485283 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of recombinant serine-rich 45-kDa antigen (ML0411) for detection of antibodies in leprosy patients. Parkash O; Kumar A; Nigam A; Franken KL; Ottenhoff TH Scand J Immunol; 2006 Oct; 64(4):450-5. PubMed ID: 16970689 [TBL] [Abstract][Full Text] [Related]
11. Performance of recombinant ESAT-6 antigen (ML0049) for detection of leprosy patients. Parkash O; Pandey R; Kumar A; Kumar A Lett Appl Microbiol; 2007 May; 44(5):524-30. PubMed ID: 17451520 [TBL] [Abstract][Full Text] [Related]
12. Leprosy reactions: humoral and cellular immune responses to M. leprae, 65kDa, 28kDa, and 18 kDa antigens. Mohanty KK; Joshi B; Katoch K; Sengupta U Int J Lepr Other Mycobact Dis; 2004 Jun; 72(2):149-58. PubMed ID: 15301588 [TBL] [Abstract][Full Text] [Related]
13. Serum calcium and magnesium in leprosy. Nigam P; Dayal SG; Sriwastava P; Joshi LD Asian J Infect Dis; 1979 Jun; 3(2):81-3. PubMed ID: 543816 [TBL] [Abstract][Full Text] [Related]
14. Association between anti-pGL-I IgM and clinical and demographic parameters in leprosy. Schuring RP; Moet FJ; Pahan D; Richardus JH; Oskam L Lepr Rev; 2006 Dec; 77(4):343-55. PubMed ID: 17343221 [TBL] [Abstract][Full Text] [Related]
15. Profile of new cases of childhood leprosy in a hospital setting. Vara N Indian J Lepr; 2006; 78(3):231-6. PubMed ID: 17120506 [TBL] [Abstract][Full Text] [Related]
16. The INFIR Cohort Study: investigating prediction, detection and pathogenesis of neuropathy and reactions in leprosy. Methods and baseline results of a cohort of multibacillary leprosy patients in north India. van Brakel WH; Nicholls PG; Das L; Barkataki P; Suneetha SK; Jadhav RS; Maddali P; Lockwood DN; Wilder-Smith E; Desikan KV Lepr Rev; 2005 Mar; 76(1):14-34. PubMed ID: 15881033 [TBL] [Abstract][Full Text] [Related]
17. [Preliminary study on leprosy subclinical infection and its sero-epidemiology]. Weng X Zhonghua Liu Xing Bing Xue Za Zhi; 1990 Feb; 11(1):16-9. PubMed ID: 2322940 [TBL] [Abstract][Full Text] [Related]
18. Utility of serodiagnostic tests for leprosy: a study in an endemic population in South India. Sinha S; Kannan S; Nagaraju B; Sengupta U; Gupte MD Lepr Rev; 2004 Sep; 75(3):266-73. PubMed ID: 15508903 [TBL] [Abstract][Full Text] [Related]
19. Utility of measuring serum levels of anti-PGL-I antibody, neopterin and C-reactive protein in monitoring leprosy patients during multi-drug treatment and reactions. Silva EA; Iyer A; Ura S; Lauris JR; Naafs B; Das PK; Vilani-Moreno F Trop Med Int Health; 2007 Dec; 12(12):1450-8. PubMed ID: 18076551 [TBL] [Abstract][Full Text] [Related]
20. Observations on reactions of leprosy in the field. Desikan KV; Sudhakar KS; Tulasidas I; Rao PV Indian J Lepr; 2007; 79(1):3-9. PubMed ID: 17578264 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]